Similar articles

• The effect of including C-reactive protein in cardiovascular risk prediction models for women.

  Cook NR, Buring JE, Ridker PM. Cook NR, et al. Ann Intern Med. 2006 Jul 4;145(1):21-9. doi: 10.7326/0003-4819-145-1-200607040-00128. Ann Intern Med. 2006. PMID: 16818925
• Cardiovascular disease screening.

  Duffy JY, Hameed AB. Duffy JY, et al. Semin Perinatol. 2015 Jun;39(4):264-7. doi: 10.1053/j.semperi.2015.05.004. Epub 2015 Jul 2. Semin Perinatol. 2015. PMID: 26143091 Review.
• Six-year change in high-sensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality.

  Parrinello CM, Lutsey PL, Ballantyne CM, Folsom AR, Pankow JS, Selvin E. Parrinello CM, et al. Am Heart J. 2015 Aug;170(2):380-9. doi: 10.1016/j.ahj.2015.04.017. Epub 2015 Apr 18. Am Heart J. 2015. PMID: 26299237 Free PMC article.
• C-reactive protein and cardiovascular disease risk: still an unknown quantity?

  Davey Smith G, Timpson N, Lawlor DA. Davey Smith G, et al. Ann Intern Med. 2006 Jul 4;145(1):70-2. doi: 10.7326/0003-4819-145-1-200607040-00130. Ann Intern Med. 2006. PMID: 16818931 No abstract available.
• Cardiovascular Risk Assessment.

  Pletcher MJ, Moran AE. Pletcher MJ, et al. Med Clin North Am. 2017 Jul;101(4):673-688. doi: 10.1016/j.mcna.2017.03.002. Med Clin North Am. 2017. PMID: 28577619 Review.